These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36411135)

  • 1. Cellular and humoral immune responsiveness to inactivated Leptospira interrogans in dogs vaccinated with a tetravalent Leptospira vaccine.
    Novak A; Hindriks E; Hoek A; Veraart C; Broens EM; Ludwig I; Rutten V; Sloots A; Broere F
    Vaccine; 2023 Jan; 41(1):119-129. PubMed ID: 36411135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new tetravalent canine leptospirosis vaccine provides at least 12 months immunity against infection.
    Klaasen HL; van der Veen M; Sutton D; Molkenboer MJ
    Vet Immunol Immunopathol; 2014 Mar; 158(1-2):26-9. PubMed ID: 24054091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine Immune Response to Vaccination and Infection with Leptospira borgpetersenii Serovar Hardjo.
    Wilson-Welder JH; Alt DP; Nally JE; Olsen SC
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33762318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A canine vaccine against Leptospira serovars Icterohaemorrhagiae, Canicola and Grippotyphosa provides cross protection against Leptospira serovar Copenhageni.
    Bouvet J; Lemaitre L; Cariou C; Scotto M; Blain C; Oberli F; Cupillard L; Guigal PM
    Vet Immunol Immunopathol; 2020 Jan; 219():109985. PubMed ID: 31759261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tetravalent Leptospira bacterin protects against infection and shedding following challenge in dogs.
    Klaasen HL; van der Veen M; Molkenboer MJ; Sutton D
    Vet Rec; 2013 Feb; 172(7):181. PubMed ID: 23180149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine.
    Klaasen HL; Molkenboer MJ; Vrijenhoek MP; Kaashoek MJ
    Vet Microbiol; 2003 Aug; 95(1-2):121-32. PubMed ID: 12860082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response of dogs after vaccination against leptospirosis measured by an IgM- and IgG-specific ELISA.
    Hartman EG; van Houten M; Frik JF; van der Donk JA
    Vet Immunol Immunopathol; 1984 Oct; 7(3-4):245-54. PubMed ID: 6506449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiements with an inactivated hepatitis leptospirosis vaccine in vaccination programmes for dogs.
    Wilson JH; Hermann-Dekkers WM; Leemans-Dessy S; Meijer JW
    Vet Rec; 1977 Jun; 100(26):552-4. PubMed ID: 196386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new multivalent (DHPPi/L4R) canine combination vaccine prevents infection, shedding and clinical signs following experimental challenge with four Leptospira serovars.
    Wilson S; Stirling C; Thomas A; King V; Plevová E; Chromá L; Siedek E; Illambas J; Salt J; Sture G
    Vaccine; 2013 Jun; 31(31):3131-4. PubMed ID: 23707447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to leptospirosis: bacterins in dogs and hamsters.
    Huhn RG; Baldwin CD; Cardella MA
    Am J Vet Res; 1975 Jan; 36(1):71-4. PubMed ID: 234704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifteen-month duration of immunity for the serovar Grippotyphosa fraction of a tetravalent canine leptospirosis vaccine.
    Grosenbaugh DA; Pardo MC
    Vet Rec; 2018 Jun; 182(23):665. PubMed ID: 29459489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of renal carriage of leptospirosis in dogs by vaccination.
    Broughton ES; Scarnell J
    Vet Rec; 1985 Sep; 117(12):307-11. PubMed ID: 4060538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of antibody ELISA specific of Leptospira interrogans serovar Grippotyphosa, Canicola, and Icterohaemorrhagiae to monitor vaccine immunogenicity.
    Cariou C; Herbet G; Ripart P; Martin-Cagnon N; Bouvet J; Schneider M; Guiot AL; Cupillard L
    Vet Immunol Immunopathol; 2020 Jan; 219():109960. PubMed ID: 31760236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recent Leptospira vaccination on whole blood real-time PCR testing in healthy client-owned dogs.
    Midence JN; Leutenegger CM; Chandler AM; Goldstein RE
    J Vet Intern Med; 2012; 26(1):149-52. PubMed ID: 22182214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of immunity of a multivalent (DHPPi/L4R) canine vaccine against four Leptospira serovars.
    Wilson S; Stirling C; Thomas A; King V; Plevová E; Chromá L; Siedek E; Illambas J; Salt J; Sture G
    Vaccine; 2013 Jun; 31(31):3126-30. PubMed ID: 23707443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine leptospirosis--do we have a problem?
    André-Fontaine G
    Vet Microbiol; 2006 Oct; 117(1):19-24. PubMed ID: 16684591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, serological and echocardiographic examination of healthy field dogs before and after vaccination with a commercial tetravalent leptospirosis vaccine.
    Spiri AM; Rodriguez-Campos S; Matos JM; Glaus TM; Riond B; Reusch CE; Hofmann-Lehmann R; Willi B
    BMC Vet Res; 2017 May; 13(1):138. PubMed ID: 28545521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early protection of dogs by a leptospira bacterin.
    Marshall V; Kerr DD
    Mod Vet Pract; 1974 Jun; 55(6):430-2. PubMed ID: 4857980
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis.
    André-Fontaine G; Branger C; Gray AW; Klaasen HL
    Vet Rec; 2003 Aug; 153(6):165-9. PubMed ID: 12934727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome and proteome analysis of innate immune responses to inactivated Leptospira and bivalent Leptospira vaccines in canine 030-D cells.
    Novak A; Pennings JLA; van der Maas L; Meiring HD; Ludwig I; Verkoeijen S; Rutten V; Broere F; Sloots A
    Sci Rep; 2022 Aug; 12(1):13418. PubMed ID: 35927283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.